Innovation Pharmaceuticals Inc IPIX:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 11:31 AM EDT
0.0013quote price arrow down-0.0002 (-13.3333%)
Volume
113,287
52 week range
0.00 - 0.02
Loading...
  • Open0.0013
  • Day High0.0013
  • Day Low0.0013
  • Prev Close0.0015
  • 52 Week High0.02
  • 52 Week High Date05/19/23
  • 52 Week Low0.00
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap673,852.026
  • Shares Out518.35M
  • 10 Day Average Volume152,576.13
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change-73.2

KEY STATS

  • Open0.0013
  • Day High0.0013
  • Day Low0.0013
  • Prev Close0.0015
  • 52 Week High0.02
  • 52 Week High Date05/19/23
  • 52 Week Low0.00
  • 52 Week Low Date04/26/24
  • Market Cap673,852.026
  • Shares Out518.35M
  • 10 Day Average Volume152,576.13
  • Dividend-
  • Dividend Yield-
  • Beta0.41
  • YTD % Change-73.2

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-0.40
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.984M
  • ROE (TTM)-114.34%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-22,850.00%
  • Debt To Equity (MRQ)59.81%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Innovation Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is primarily focused on business development for the advancement of Brilacidin in the...
Leo Ehrlich CPA
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
Address
301 EDGEWATER PLACE, SUITE 100
Wakefield, MA
01880
United States